Filing Details
- Accession Number:
- 0001209191-17-007053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-02 16:03:05
- Reporting Period:
- 2017-01-31
- Filing Date:
- 2017-02-02
- Accepted Time:
- 2017-02-02 16:03:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595896 | James Mandell | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-31 | 8,000 | $21.43 | 9,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-31 | 8,000 | $75.04 | 1,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2017-01-31 | 8,000 | $0.00 | 8,000 | $21.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2024-01-08 | No | 4 | M | Direct |
Footnotes
- This sales reported in the Form 4 were effectd pursuant to a 10b5-1 trading plan adopted by the reporting person on December 13, 2016.
- The range in prices for the transaction reported on this line was $75.00 to $75.20. The average weighted price was $75.0402. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests ratably over three years in annual installments, commencing on January 8, 2014.
Billionaire Hedge Funds
